MTOR and breast cancer: Therefore, the present study used a molecular-targeted inhibitor library to search for drugs that suppress the self-renewal ability of CSCs derived from canine mammary cancer lines and focused on the candidate inhibitors targeting the mammalian target of rapamycin (mTOR) signaling pathway extracted by the in vitro screening.